Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial

Table 4 Relationship between log Fasting Glucose and Fetal ultrasound markers

Ultrasound Measure	Unadjusted Estimate (95% CI)	Unadjusted p value	Adjusted Estimate (95% CI)	Adjusted p value
EFW	59.68 (−33.80, 153.16)	0.211	53.52 (−56.64, 163.68)	0.341
SSFM	−0.32 (− 0.81, 0.17)	0.201	− 0.17 (− 0.74, 0.41)	0.575
AFM	− 0.54 (−1.10, 0.02)	0.058	− 0.10 (− 0.76, 0.57)	0.772
MTFM	− 0.25 (− 0.97, 0.47)	0.493	0.02 (− 0.83, 0.87)	0.959
MTLM	− 0.28 (− 0.91, 0.35)	0.387	0.03 (− 0.72, 0.77)	0.946
AC	0.16 (− 0.55, 0.88)	0.653	0.33 (− 0.50, 1.17)	0.430
BPD	0.16 (− 0.01, 0.33)	0.067	0.08 (− 0.13, 0.28)	0.460
HC	0.19 (−0.38, 0.77)	0.509	0.05 (−0.63, 0.74)	0.884
FL	0.12 (−0.01, 0.26)	0.077	0.09 (−0.07, 0.25)	0.289
EFW z score	0.33 (−0.09, 0.74)	0.120	0.46 (−0.01, 0.94)	0.057
AC z score	0.08 (−0.35, 0.51)	0.714	0.36 (−0.14, 0.87)	0.153
BPD z score	0.61 (−0.03, 1.25)	0.061	0.42 (−0.32, 1.17)	0.263
HC z score	0.10 (−0.34, 0.53)	0.659	0.07 (−0.45, 0.59)	0.800
FL z score	0.50 (0.06, 0.94)	0.027	0.49 (−0.04, 1.03)	0.071

Results are expressed as the expected difference (ratio) and 95% confidence intervals
Adjusted analyses including BMI category (< 30 vs ≥30), study centre, parity (0 vs ≥1), age at consent, smoking status and SEIFA IRSD quintile

ISSN: 1472-6823